Stock listing

7N70 Stock Price, News, Filings & Events — Alpha Cognition Inc.

Selected listing: 7N70 · FWB · EUR · DE

This page tracks Alpha Cognition Inc.'s 7N70:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 7N70:FWB. 7N70:FWB is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

7N70:FWBEURDEUpdated August 14, 2026
Alpha Cognition Inc. logo
Ticker
7N70:FWB
Asset type
Stock
Market cap
$192.5M
Sector
Finance
Industry
Financial Conglomerates
Exchange
FWB
Currency
EUR

Alpha Cognition Inc. 7N70:FWB stock context

This page tracks Alpha Cognition Inc.'s 7N70:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 7N70:FWB. 7N70:FWB is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

Research Alpha Cognition Inc.

Alternate listings